Clinical Trial Forms | FDA - U.S. Food and Drug Administration
Mar 7, 2022 · This page provides links to commonly used clinical trial forms relevant to clinical trials. For other FDA forms, visit the FDA Forms page.
complete the Statement of Investigator form (Form FDA 1572). The Food and Drug Administration (FDA or agency) has received a number of questions about Form FDA 1572.
Frequently Asked Questions-Statement of Investigator (Form FDA 1572 ...
May 20, 2021 · The Food and Drug Administration (FDA, Agency, or we) is announcing the availability of a draft information sheet guidance for sponsors, clinical investigators, and institutional review boards (IRBs) entitled “Frequently Asked Questions—Statement of Investigator (Form FDA 1572) (Revision 1).”
Revisiting the Form FDA 1572 - ACRP
Apr 25, 2019 · What is the Form FDA 1572 (Statement of Investigator)? The Statement of Investigator (Form FDA 1572) is a form that is required to be filled for clinical trials involving investigational drugs or biologics.
This form instruction is to assist clinical investigators in completing Form FDA 1572 Statement of Investigator. Form FDA 1572 has two purposes: 1) to provide the sponsor with information about the Principal
Frequently Asked Questions – Statement of Investigator (Form FDA 1572)
It describes how to complete the Statement of Investigator form (Form FDA 1572). The Food and Drug Administration (FDA or agency) has received a number of questions about Form FDA 1572. The...
What the purpose of Form FDA 1572 is. The commitments the investigator agrees to by signing Form FDA 1572. When Form FDA 1572 is required to be completed. How to fill out Form FDA 1572. What is Form FDA 1572? Why Does the Form Need to be Completed by the Investigator?
IND Forms and Instructions | FDA
Mar 31, 2022 · FDA's receipt of the IND Forms: Form FDA 1571 (PDF - 221KB): Investigational New Drug Application (IND) Form FDA 1572 (PDF - 208KB): Statement of Investigator
The Statement of Investigator, Form FDA 1572 (1 572), is an agreement signed by the investigator to provide certain information to the sponsor and assure that helshe will comply with FDA regulations related to the conduct of a clinical investigation of an investigational drug or
Mar 31, 2019 · N/A – The Cancer Therapy Evaluation Program, National Cancer Institute requires each investigator to submit a separate FDA Form 1572, CV, Supplemental Investigator Data Form, and Financial Disclosure Form.